Albany, NY -- (SBWIRE) -- 02/12/2019 -- ResearchMoz.us has recently added a fresh report to its vast repository titled "Global Age-related macular degeneration Market Insights, Forecast to 2025." to its offering. The report provides an in-depth analysis of the age related mascular degeneration (DMD) therapeutic market. The report provides the key drivers and restraints impacting overall growth of the global age-related macular degeneration therapeutics market. The current and future analysis of this market is also provided in the research report. The competitive landscape of the global age-related macular degeneration therapeutics market is also included in the research report.
The visual impairment case is growing among the geriatric population which is an acquired retinal disorder and also causes deterioration of macula. The market for Age-related macular degeneration is majorly driven by rising number of patients across the globe. These are some of the factors promoting growth of the global age-related macular degeneration therapeutics market. As per American Academy of Ophthalmology, around 11 millions American are majoly affected with the age-related macular degeneration. This can be another factor promoting growth of this market in the coming years. In addition, the rising prevalence of age-related macular degeneration is high among the sub-Saharan Africa and South East Asia owing to Vitamin A deficiency and this is likely to support growth of the global market.
Get a Sample PDF with Tables and Figures at: https://www.researchmoz.us/enquiry.php?type=S&repid=2081177
The advancement in technology in the healthcare industry and upgrade diagnostic is another factor driving growth of the global Age-related macular Degeneration market.
On the other hand, high cost associated with the treatment and strict government policy and rising off-label utilization are some of the factors majorly hampering growth of the age-related macular degeneration market. For example, single injection of anti-vascular endothelial growth factor (anti VEGF) agent for the treatment of age-related macular degeneration therapeutics for instance ranibizumab charge is around $2000.However, the increase in elderly population and growing awareness among the population about the age-related macular degeneration therapeutics is likely to provides lucrative opportunities in the global market in the foreseeable future.
From the geographical point of view, North America dominate the global age-related macular degeneration therapeutics market owing to the increasing number of people in America affected from Age-related macular degeneration and they are now benefiting from the advanced treatment choice such as photodynamic therapy (PDT) and anti-VEGF agents. Moreover, the high cost associated with the therapy helps in expanding North America the age-related macular degeneration therapeutics market. However, other economies such as Asia Pacific is likely to account for more than one third case of the age-related macular degeneration therapeutics and the market is likely to grow more rapidly than in America and Europe and hence market in age-related macular degeneration therapeutics Asia Pacific is expected to grow at healthy pace during the course of forecast period.
The prominent players operating in the global age-related macular degeneration therapeutics are Genentech, Inc.,Valeant Pharmaceuticals International, Inc. and Novartis AG. The manufacturers are largely focused towards mergers and acquisitions in order to create new product and to strengthen their presence across the globe.
About ResearchMoz
ResearchMoz is the world's fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz's service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.
Contact Us:
Mr. Nachiket
Albany NY - 12207
United States
Tel: +1-518-621-2074
Tel: 866-997-4948 (Us-Canada Toll Free)
Email: sales@researchmoz.us